Search
for
Sort by
Research 301–330 of 412
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- The connection of 5-alpha reductase inhibitors to the development of depression
- Development and Validation of Spectrophotometric Method for Determination of Finasteride in Pharmaceutical Formulation Using 1,2-Naphthoquine-4-sulfonate (NQS)
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings
- The pattern of off-label and unlicensed drug use in adult and pediatric patients in the Kingdom of Saudi Arabia: multicenter retrospective study
- Finasteride use during pregnancy and early neonatal outcome: a case report
- Acquired Localized Hypertrichosis Induced by Rivastigmine
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- The Use of Anabolic Steroids by Bodybuilders in the State of Sergipe, Brazil
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Pregnancy and neonatal outcome with maternal exposure to finasteride: Case series
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- LAM/TSC Cell Migration to Uterus in an Experimental Model of Lymphangioleiomyomatosis. Regulation by Anti-Epidermal Growth Factor Receptor Antibody and Rapamycin
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- Advances in hair growth
- The switch from patented medicine to the generic one: an option or a necessity?
- Analysis of changes in microRNA expression profiles in response to the troxerutin-mediated antioxidant effect in human dermal papilla cells